BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38664865)

  • 1. Subsequent malignant neoplasms after primary hematological malignancy in adult patients.
    Rönkkö RM; Nevala AO; Pitkäniemi JM; Wartiovaara-Kautto UM; Malila NK
    Int J Cancer; 2024 Apr; ():. PubMed ID: 38664865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.
    Baker KS; Leisenring WM; Goodman PJ; Ermoian RP; Flowers ME; Schoch G; Storb R; Sandmaier BM; Deeg HJ
    Blood; 2019 Jun; 133(26):2790-2799. PubMed ID: 30992266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
    Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
    J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort.
    Trama A; Tittarelli A; Barigelletti G; Botta L; Gatta G; Tagliabue G; Contiero P; Guzzinati S; Andreano A; Manneschi G; Falcini F; Castaing M; Filiberti RA; Gasparotti C; Cirilli C; Mazzucco W; Mangone L; Iacovacci S; Vitale MF; Stracci F; Piffer S; Tumino R; Carone S; Sampietro G; Melcarne A; Ballotari P; Boschetti L; Pisani S; Cavalieri D'Oro L; Cuccaro F; D'Argenzio A; D'Orsi G; Fanetti AC; Ardizzone A; Candela G; Savoia F; Pascucci C; Castelli M; Storchi C; Bernasconi A
    Cancer; 2022 Jan; 128(2):364-372. PubMed ID: 34582036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
    Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
    Feng J; Jin G; Song X
    Adv Ther; 2022 Jun; 39(6):2533-2543. PubMed ID: 35357667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.
    Geurts YM; Neppelenbroek SIM; Aleman BMP; Janus CPM; Krol ADG; van Spronsen DJ; Plattel WJ; Roesink JM; Verschueren KMS; Zijlstra JM; Koene HR; Nijziel MR; Schimmel EC; de Jongh E; Ong F; Te Boome LCJ; van Rijn RS; Böhmer LH; Ta BDP; Visser HPJ; Posthuma EFM; Bilgin YM; Muller K; van Kampen D; So-Osman C; Vermaat JSP; de Weijer RJ; Kersten MJ; van Leeuwen FE; Schaapveld M
    ESMO Open; 2024 Feb; 9(2):102248. PubMed ID: 38350338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
    Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
    PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative risk of second malignant neoplasms highest among young adult cancer patients - a population-based registry study in Finland.
    Koivisto HAM; Nevala AO; Miettinen JM; Pitkäniemi JM; Malila NK; Heikkinen SMM
    Acta Oncol; 2024 Jun; 63():418-425. PubMed ID: 38850051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of second malignancies in individuals diagnosed with malignant peripheral nerve sheath tumors.
    Williams LA; Moertel CL; Richardson M; Marcotte EL
    J Neurooncol; 2020 May; 147(3):701-709. PubMed ID: 32239432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
    Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
    Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
    Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
    Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
    Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
    Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
    Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.